Why was it so important to study the 1918 virus?

Dr. Tumpey: Because the coding sequences of the 1918 viral RNA segments did not reveal obvious genetic features that had been associated with virulence, so it was important to study 1918 recombinant viruses to better understand the genetic markers responsible for virus replication and virulence of this pandemic strain. Thus, I felt like the molecular characterization of the reconstructed 1918 pandemic influenza virus shed light on why this virus was such a killer.

This image lists lessons learned from the study of the reconstructed 1918 virus at CDC and why it was so deadly.

What did you learn about why the 1918 pandemic virus was so deadly?

Dr. Tumpey: We found that the HA and PB1 virus genes of the 1918 virus are essential for maximal replication and virulence. With these data in hand, some scientists felt that these virus genes could be a potential target for a new generation of anti-influenza A drug development. We feel that the quality of the 1918 virus work and end result of the project was remarkable.

How do laboratory safety precautions factor into your job and that of your branch?

Dr. Tumpey: It is increasingly important that staff adhere to biosafety and biosecurity requirements. I am a Select Agent principal investigator (PI), and as PI, I am responsible for full compliance with the policies, practices and procedures put forward by the Select Agent program and Office of the Associated Director of Laboratory Science and Safety (OADLSS). Actually, this important responsibility extends to all aspects of biological safety involving the laboratory environment and all people who enter the BSL-3E space.

What role did you play during the 2009 H1N1 pandemic? 

Dr. Tumpey: My role during the 2009 H1N1 pandemic was to perform laboratory experiments with 2009 H1N1 influenza viruses to see how well the virus spread and how severe it was as well as to help evaluate immunity to this novel virus. This helped us assess the potential harm this virus could cause. This was important since the full clinical spectrum of disease caused by 2009 H1N1 influenza viruses and their transmissibility were not completely understood. CDC’s Influenza Division was the first to show that in contrast to seasonal influenza viruses, 2009 H1N1 influenza viruses caused increased morbidity, replicated to higher titers in lung tissue, and were recovered from the intestinal tract of intranasally inoculated ferrets. Interestingly, we found similarities between the 2009 pandemic H1N1 virus and the 1918 H1N1 virus. This was based on several serological studies of the 2009 H1N1 viruses that provided evidence for the presence of cross-reactive antibodies to the 1918 H1N1 virus. Using this information, we demonstrated that vaccination with the seasonal 2010-2011 vaccine (containing the 2009 H1N1 virus) induced neutralizing antibodies to the 1918 virus and protected ferrets against 1918 influenza virus infection. This was a simple study that showed that the seasonal inactivated influenza vaccine that most of us receive would provide protection against the reconstructed 1918 virus which, as a select agent, is considered to pose both biosafety and biosecurity threats.

Do you have any final thoughts on how the lessons learned from your research can help us prepare for the next pandemic?

Taken together, influenza vaccines and antiviral drugs represent critical tools to reduce the burden of influenza virus infection, and they feature prominently in pandemic preparedness and response frameworks. Through the identification of which 1918 virus genes are important for morbidity and the development of vaccines and antivirals, it is clear that reconstruction of the 1918 virus has provided invaluable information towards pandemic preparedness efforts.

Thank you for your time, Dr. Tumpey!

This concludes our CDC expert interview. For more information on Dr. Tumpey’s work and the 100-year anniversary of the 1918 pandemic, please see Dr. Tumpey’s Flu Fighter profile article and CDC’s 1918 pandemic commemoration page.

Pages: 1 · 2

More Articles

• Magazines and the American Experience: Highlights from the Collection of Steven Lomazow, M.D
• From the Office of the Historian: Office of Art & Archives, Office of the Clerk: The 1954 Shooting Onto the House of Representatives
• ‘Cruel’ Digital Race For Vaccines Leaves Many Seniors Behind; Challenges Facing Seniors Speak To the Country’s Fragmented Approach
• Jo Freeman Reviews Stories from Trailblazing Women Lawyers: Lives in the Law by Jill Norgren
• Jill Norgren Writes: My Choices of Good Reads For The Past Year
• Jo Freeman: Five Days in DC Where the Post-election Protests Were Puny but the Politics Were Not
• Updated Subsidy Calculator and 300+ FAQs Help Consumers Understand the ACA Marketplaces as Open Enrollment Begins
• Jill Norgren Writes: Did Women in the US Campaign for Elective Office Fully Invested in the Prospect of Winning? “I cannot vote, but I can be voted for”
• Ruth Bader Ginsburg's Partial Remarks at the University of Buffalo, August 26, 2019: "If I am notorious, it is because I had the good fortune to be alive and a lawyer in the late 1960s"
• Covid 19 Hearing Sept 16th: CDC Director Dr. Redfield Testified on the Latest Coronavirus Response Efforts